APA (7th ed.) Citation

Kosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Rasmussen, S., Davies, M., . . . Petrie, M. C. (2023). Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. The New England journal of medicine, 389(12), 1069-1084. https://doi.org/10.1056/NEJMoa2306963

Chicago Style (17th ed.) Citation

Kosiborod, Mikhail N., et al. "Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity." The New England Journal of Medicine 389, no. 12 (2023): 1069-1084. https://doi.org/10.1056/NEJMoa2306963.

MLA (9th ed.) Citation

Kosiborod, Mikhail N., et al. "Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity." The New England Journal of Medicine, vol. 389, no. 12, 2023, pp. 1069-1084, https://doi.org/10.1056/NEJMoa2306963.